Παρασκευή 8 Δεκεμβρίου 2017

Novel in vitro cancer models for optimizing anti-EGFR therapies

Pre-clinical models, that are able to recapitulate the biology and pathology of the original individual cancer, are needed to better investigate mechanisms of response and resistance to anticancer therapies. In this respect, novel in vitro models for metastatic colorectal cancer could be of high value.



from Cancer via ola Kala on Inoreader http://ift.tt/2nKVSZO
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου